The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity.
Open accessAbstract
Immunosuppressants FK506 and cyclosporin A inhibit neurotoxicity of N-methyl-D-aspartate in primary cortical cultures, while having no effect on quisqualate- and kainate-mediated neurotoxicity. Rapamycin completely reverses the neuroprotective effect of FK506. Both FK506 and cyclosporin A inhibit NMDA-elicited/nitric oxide-mediated increases in cGMP levels in cortical cultures. FK506 has no effect on sodium nitroprusside-induced increases in cGMP. In a stably transfected human kidney 293 cell line overexpressing the gene encoding nitric oxide synthase [L-arginine, NADPH:oxygen oxidoreductase (nitric oxide-forming), EC 1.14.13.39], FK506 inhibits the calcium ionophore A23187, stimulated increases in nitrite (a breakdown product of nitric oxide), and potentiates phorbol ester-mediated inhibition of nitrite formation. FK506-mediated inhibition of nitric oxide formation is completely reversed by rapamycin. Calcineurin dephosphorylates protein kinase C-mediated phosphorylation of nitric oxide synthase. FK506 prevents the calcineurin-mediated dephosphorylation of nitric oxide synthase and thereby diminishes the enzyme's catalytic activity. These data establish nitric oxide synthase as a calcineurin substrate. Nitric oxide synthase catalytic activity is regulated by the phosphorylation state of the enzyme. Enhanced phosphorylation of nitric oxide synthase diminishes catalytic activity, and dephosphorylation (through activation of calcineurin) enhances catalytic activity. The neuroprotective effect of FK506 and cyclosporin A presumably involves the inhibition of calcineurin, preventing the dephosphorylation of nitric oxide synthase and its subsequent activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Glutamate, nitric oxide and cell-cell signalling in the nervous system
Garthwaite, J. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90022-m · Cited by 2,402
Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R., & Snyder, S. H. (1991) · Nature · doi:10.1038/351714a0 · Cited by 2,354
Self-citationNitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., & Snyder, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6368 · Cited by 2,174
Self-citationNitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.
Bredt, D. S., & Snyder, S. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.9030 · Cited by 1,840
Self-citationExcitatory amino acid neurotoxicity and neurodegenerative disease
Meldrum, B., & Garthwaite, J. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90184-a · Cited by 1,771
Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands
Schreiber, S. L. (1991) · Science · doi:10.1126/science.1702904 · Cited by 1,494
Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
Dawson, V., Dawson, T., Bartley, D., Uhl, G., & Snyder, S. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02651.1993 · Cited by 1,014
Self-citationA novel neuronal messenger molecule in brain: The free radical, nitric oxide
Dawson, T. M., Dawson, V. L., & Snyder, S. H. (1992) · Annals of Neurology · doi:10.1002/ana.410320302 · Cited by 834
Self-citationCalcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.
Fruman, D. A., Klee, C. B., Bierer, B. E., & Burakoff, S. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3686 · Cited by 823
Bredt, D. S., Ferris, C. D., & Snyder, S. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49862-1 · Cited by 609
Self-citationLiu, J., Albers, M. W., Wandless, T. J., Luan, S., Alberg, D. G., Belshaw, P. J., Cohen, P., MacKintosh, C., Klee, C. B., & Schreiber, S. L. (1992) · Biochemistry · doi:10.1021/bi00131a002 · Cited by 558
Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse
Nowicki, J. P., Duval, D., Poignet, H., & Scatton, B. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90862-k · Cited by 503
Pharmacological and functional characteristics of metabotropic excitatory amino acid receptors
Schoepp, D., Bockaert, J., & Sladeczek, F. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90052-a · Cited by 462
Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices
Halpain, S., Girault, J.-A., & Greengard, P. (1990) · Nature · doi:10.1038/343369a0 · Cited by 357
High brain densities of the immunophilin FKBP colocalized with calcineurin
Steiner, J. P., Dawson, T. M., Fotuhi, M., Glatt, C. E., Snowman, A. M., Cohen, N., & Snyder, S. H. (1992) · Nature · doi:10.1038/358584a0 · Cited by 345
Self-citationAssociation of a 59-kilodalton immunophilin with the glucocorticoid receptor complex
Tai, P.-K. K., Albers, M. W., Chang, H., Faber, L. E., & Schreiber, S. L. (1992) · Science · doi:10.1126/science.1376003 · Cited by 304
Neurons Containing NADPH-Diaphorase Are Selectively Resistant to Quinolinate Toxicity
Koh, J.-Y., Peters, S., & Choi, D. W. (1986) · Science · doi:10.1126/science.2875522 · Cited by 287
Nakane, M., Mitchell, J., Förstermann, U., & Murad, F. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81351-8 · Cited by 274
Activation of NMDA receptors induces rapid dephosphorylation of the cytoskeletal protein MAP2
Halpain, S., & Greengard, P. (1990) · Neuron · doi:10.1016/0896-6273(90)90161-8 · Cited by 220
Bench to Bedside: The Glutamate Connection
Choi, D. W. (1992) · Science · doi:10.1126/science.1357748 · Cited by 204
Thomson, A. W. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90057-1 · Cited by 181
Nitric oxide inhibitors attenuate excitotoxicity in rat hippocampal slices
Izumi, Y., Benz, A. M., Clifford, D. B., & Zorumski, C. F. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90442-a · Cited by 175
Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13.
Jin, Y. J., Albers, M. W., Lane, W. S., Bierer, B. E., Schreiber, S. L., & Burakoff, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6677 · Cited by 173
Yem, A. W., Tomasselli, A. G., Heinrikson, R. L., Zurcher-Neely, H., Ruff, V. A., Johnson, R. A., & Deibel, M. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50664-0 · Cited by 167
Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B.
Swanson, S. K., Born, T., Zydowsky, L. D., Cho, H., Chang, H. Y., Walsh, C. T., & Rusnak, F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3741 · Cited by 166
A rapamycin-selective 25-kDa immunophilin
Gałat, A., Lane, W. S., Standaert, R. F., & Schreiber, S. L. (1992) · Biochemistry · doi:10.1021/bi00123a031 · Cited by 129
Permeability of the Blood‐Brain Barrier to the Immunosuppressive Cyclic Peptide Cyclosporin A
Begley, D. J., Squires, L. K., Zloković, B. V., Mitrovic, D. M., Hughes, C. C. W., Revest, P., & Greenwood, J. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb03128.x · Cited by 128
Effect of NO synthase inhibition on NMDA- and ischaemia-induced hippocampal lesions
Moncada, C., Lekieffre, D., Arvin, B. M., & Meldrum, B. S. (1992) · Neuroreport · doi:10.1097/00001756-199206000-00020 · Cited by 127
Properties of vertebrate glutamate receptors: Calcium mobilization and desensitization
Zorumski, C. F., & Thio, L. L. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90020-f · Cited by 118
Metabotropic excitatory amino acid receptors reveal their true colors
Miller, R. J. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90604-q · Cited by 91
Molecular cloning of a 25-kDa high affinity rapamycin binding protein, FKBP25.
Jin, Y. J., Burakoff, S. J., & Bierer, B. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49856-6 · Cited by 85
FK506 and rapamycin: novel pharmacological probes of the immune response
CHANG, J. Y., Sehgal, S. N., & Bansbach, C. C. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90555-7 · Cited by 85
Glutamate-stimulated protein phosphorylation in cultured hippocampal pyramidal neurons
Scholz, W., & Palfrey, H. C. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-08-02422.1991 · Cited by 48
Puttfarcken, P. S., Lyons, W. E., & Coyle, J. T. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90189-v · Cited by 48
Inhibition of nitric oxide synthase protects against hypoxic neuronal injury
Wallis, R. A., Panizzon, K. L., & Wasterlain, C. G. (1992) · Neuroreport · doi:10.1097/00001756-199207000-00026 · Cited by 45
Pharmacologic Properties of NMDA Receptors
Mayer, M. L., Benveniste, M., Patneau, D. K., & Vyklický, L. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24538.x · Cited by 32
Cited by
Regulation of biosynthesis of nitric oxide.
Nathan, C., & Xie, Q. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36703-0 · Cited by 1,669
Calcineurin: Form and Function
Rusnak, F., & Mertz, P. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1483 · Cited by 1,373
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.
Förstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., & Kleinert, H. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1121 · Cited by 1,111
Gases as biological messengers: nitric oxide and carbon monoxide in the brain
Dawson, T., & Snyder, S. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05147.1994 · Cited by 1,043
Self-citationBright and dark sides of nitric oxide in ischemic brain injury
Iadecola, C. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10074-6 · Cited by 1,046
Metadata
- Authors
- Dawson, T. M., Steiner, J. P., Dawson, V. L., Dinerman, J. L., Uhl, G. R., & Snyder, S. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-11
- Volume
- 90
- Issue
- 21
- Pages
- 9808-9812
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2055183364
- Cited by
- 538
- References
- 39
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.